the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Muhyiddin has no moral standing to talk about other issues – Fahmi

KUALA LUMPUR: Perikatan Nasional chairman Tan Sri Muhyiddin Yassin has no moral standing to make statements regarding current affairs in the country, including political issues, said PKR Information chief Fahmi Fadzil.

Fahmi, who is also the Communications Minister, said this was due to Muhyiddin’s failure to cooperate with the authorities in urging his son-in-law, Datuk Seri Muhammad Adlan Berhan, to return and face criminal breach of trust charges made against him by the Malaysian Anti-Corruption Commission.

“Do not talk about Kuala Kubu Baharu or by-elections. Bring back your son-in-law, and then you will be in a better position to talk because he (Muhammad Adlan) is a fugitive from justice.

“As a leader, he (Muhyiddin) should be setting a good example by urging his son-in-law to return to Malaysia and face the investigation that has been initiated.

“If he fails to do so, then I believe he has no moral standing to talk about anything else,” Fahmi told reporters after attending the Lembah Pantai Hari Raya Aidilfitri 2024 Open House at IWK Eco Park @ Pantai Dalam here last night.

He was commenting on Muhyiddin’s statement claiming that the Unity Government is on the verge of splitting up due to ‘conflict’ between leaders of Pakatan Harapan and Barisan Nasional regarding the addendum order involving former prime minister Datuk Seri Najib Tun Razak.

The Kuala Kubu Bahru by-election is being called following the demise of its incumbent, Lee Kee Hiong, from DAP on March 21.

The Election Commission has set polling day for May 11, while nomination and early voting will be on April 27 and May 7 respectively.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings